Published: Sat. five November 2022, 16: 00
On Friday, the UAE’s Ministry of Health and Prevention reported 274 cases of Covid-19 coronavirus, including 286 recoveries and no deaths.
Pfizer-BioNTech said Thursday it will test a combined coronavirus-flu vaccine that could pave the way for further absorption of inoculation for either disease.
The corporations said in a statement that the combined mRNA-based vaccine candidate is expected to move into a phase one trial in the U. S. 180 volunteers.
Inoculation “could simplify vaccination practices opposed to those two respiratory pathogens, which could lead to increased vaccination policy for either disease,” said Annaliesa Anderson, director of vaccines and progression at U. S. drugmaker Pfizer.
“Even with existing seasonal flu vaccines, the burden of this virus is severe worldwide, causing thousands of deaths and hospitalizations a year. “
Pfizer and its German partner BioNTech have developed one of the most widely used vaccines to fight Covid-19.
Rival vaccine makers Moderna and Novavax have tested combined inoculations against covid and influenza.
READ ALSO: